Vol 15, No 1 (2022)
Review paper
Published online: 2022-03-31

open access

Page views 5681
Article views/downloads 868
Get Citation

Connect on Social Media

Connect on Social Media

Influence of chronic coffee consumption on the risk of kidney and other organ diseases. Review of the literature and clinical studies

Stanisław Surma1, Franciszek Kokot1
DOI: 10.5603/RDTF.2021.0015
Renal Disease and Transplantation Forum 2022;15(1):1-18.


Due to its taste and biological properties, coffee has been a very popular drink for centuries. The average coffee consumption in Poland amounts to 3 kg per capita/year and systematically increases year by year. The most popular types of coffee grown in the world are Coffea arabica, Coffea canephora, and Coffea liberica. The biochemical composition of coffee depends on many factors, mainly the type of coffee and the method of its cultivation and production. Coffee contains over 1000 different chemical compounds, the most prevalent being caffeine, chlorogenic acid, trigonelline, kahweol, and cafestol. All of these compounds are characterized by high biological activity. A number of exogenous and endogenous factors affect the rate of caffeine metabolism, which may have important clinical implications. In addition, caffeine can interact with medications in various ways, increasing the risk of side effects. Numerous studies indicate both the beneficial and unfavorable effects of coffee consumption on human health. This review paper presents the effect of coffee consumption on the risk of developing diseases of the kidney, nervous system, digestive system, cardiovascular system, and metabolic diseases.

Article available in PDF format

View PDF Download PDF file


  1. Romualdo GR, Rocha AB, Vinken M, et al. Drinking for protection? Epidemiological and experimental evidence on the beneficial effects of coffee or major coffee compounds against gastrointestinal and liver carcinogenesis. Food Res Int. 2019; 123: 567–589.
  2. Surma S, Narkiewicz K. Kawa a ryzyko rozwoju nadciśnienia tętniczego i innych chorób układu krążenia. Choroby Serca i Naczyń. 2020; 17(1): 55–64.
  3. https://kawa.pl/artykuly/kawa-w-liczbach-czyli-garsc-statystyk/. 30/3/2021.
  4. Lenart B. Na kawowym szlaku. Przegl Gastronom. 2006; 32(7-8): 32–8.
  5. Rubayiza AB, Meurens M. Chemical discrimination of arabica and robusta coffees by Fourier transform Raman spectroscopy. J Agric Food Chem. 2005; 53(12): 4654–4659.
  6. Zgodka A, Lenart A. Wpływ składu surowcowego na właściwości mechaniczne kawy palonej mielonej. Inż Rol. 2005; 9: 419–427.
  7. Saw AC, Yam WS, Wong KC, et al. A comparative study of the volatile constituents of southeast Asian Coffea arabica, Coffea liberica and Coffea robusta green beans and their antioxidant activities. Journal of Essential Oil Bearing Plants. 2015; 18(1): 64–73.
  8. Wintgens J. Factors influencing the quality of green coffee. In: Wintgens J. ed. Coffee: Growing, Processing, Sustainable Production. A Guidebook for Growers, Processors, Traders and Researchers. Wiley-VCH, Weinheim 2009: 797–817.
  9. Gonzalez de Mejia E, Ramirez-Mares MV. Impact of caffeine and coffee on our health. Trends Endocrinol Metab. 2014; 25(10): 489–492.
  10. McCusker RR, Fuehrlein B, Goldberger BA, et al. Caffeine content of decaffeinated coffee. J Anal Toxicol. 2006; 30(8): 611–613.
  11. Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018; 70(2): 384–411.
  12. Lang R, Dieminger N, Beusch A, et al. Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal Bioanal Chem. 2013; 405(26): 8487–8503.
  13. Stalmach A, Steiling H, Williamson G, et al. Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy. Arch Biochem Biophys. 2010; 501(1): 98–105.
  14. Kuhn M, Lang S, Bezold F, et al. Time-resolved extraction of caffeine and trigonelline from finely-ground espresso coffee with varying particle sizes and tamping pressures. Journal of Food Engineering. 2017; 206: 37–47.
  15. López-Galilea I, De Peña MP, Cid C. Correlation of selected constituents with the total antioxidant capacity of coffee beverages: influence of the brewing procedure. J Agric Food Chem. 2007; 55(15): 6110–6117.
  16. Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol. 1997; 35(6): 547–554.
  17. Nieber K. The impact of coffee on health. Planta Med. 2017; 83(16): 1256–1263.
  18. Díaz-Rubio ME, Saura-Calixto F. Dietary fiber in brewed coffee. J Agric Food Chem. 2007; 55(5): 1999–2003.
  19. Lopes G, Ferreira A, Pinto M, et al. Carbohydrate content, dietary fibre and melanoidins: Composition of espresso from single-dose coffee capsules. Food Research International. 2016; 89: 989–996.
  20. Fogliano V, Morales FJ. Estimation of dietary intake of melanoidins from coffee and bread. Food Funct. 2011; 2(2): 117–123.
  21. de Melo Pereira GV, de Carvalho Neto DP, Magalhães Júnior AI, et al. Chemical composition and health properties of coffee and coffee by-products. Adv Food Nutr Res. 2020; 91: 65–96.
  22. Wu L, Meng J, Shen Q, et al. Caffeine inhibits hypothalamic AR to excite oxytocin neuron and ameliorate dietary obesity in mice. Nat Commun. 2017; 8: 15904.
  23. Ren Y, Wang C, Xu J, et al. Cafestol and kahweol: A review on their bioactivities and pharmacological properties. Int J Mol Sci. 2019; 20(17).
  24. Marx B, Scuvée É, Scuvée-Moreau J, et al. [Mechanisms of caffeine-induced diuresis]. Med Sci (Paris). 2016; 32(5): 485–490.
  25. Liszt KI, Ley JP, Lieder B, et al. Caffeine induces gastric acid secretion via bitter taste signaling in gastric parietal cells. Proc Natl Acad Sci U S A. 2017; 114(30): E6260–E6269.
  26. Zuman W, Loh S, Esa N. Coffee and gastrointestinal health: a review. Malaysian Journal of Medicine and Health Sciences. 2019; 15: 96–103.
  27. Naveed M, Hejazi V, Abbas M, et al. Chlorogenic acid (CGA): A pharmacological review and call for further research. Biomed Pharmacother. 2018; 97: 67–74.
  28. Higashi Y. Coffee and endothelial function: a coffee paradox? Nutrients. 2019; 11(9).
  29. Peters BA, McCullough ML, Purdue MP, et al. Association of coffee and tea intake with the oral microbiome: results from a large cross-sectional study. Cancer Epidemiol Biomarkers Prev. 2018; 27(7): 814–821.
  30. González S, Salazar N, Ruiz-Saavedra S, et al. Long-term coffee consumption is associated with fecal microbial composition in humans. Nutrients. 2020; 12(5).
  31. Kim Y, Je Y, Giovannucci E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019; 34(8): 731–752.
  32. Je Y, Giovannucci E. Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. Br J Nutr. 2014; 111(7): 1162–1173.
  33. Loftfield E, Cornelis MC, Caporaso N, et al. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: Findings from the UK biobank. JAMA Intern Med. 2018; 178(8): 1086–1097.
  34. Srithongkul T, Ungprasert P. Coffee consumption is associated with a decreased risk of incident chronic kidney disease: a systematic review and meta-analysis of cohort studies. Eur J Intern Med. 2020; 77: 111–116.
  35. Kennedy OJ, Pirastu N, Poole R, et al. Coffee consumption and kidney function: A mendelian randomization study. Am J Kidney Dis. 2020; 75(5): 753–761.
  36. Bigotte Vieira M, Magriço R, Viegas Dias C, et al. Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis. Nephrol Dial Transplant. 2019; 34(6): 974–980.
  37. Lew QLJ, Jafar TH, Jin A, et al. Consumption of coffee but not of other caffeine-containing beverages reduces the risk of end-stage renal disease in the Singapore Chinese health study. J Nutr. 2018; 148(8): 1315–1322.
  38. Caetano C, Valente A, Oliveira T, et al. Coffee consumption in hemodialysis patients: how many? Eur J Clin Nutr. 2019; 73(6): 924–929.
  39. Wang S, Zhang Y, Mao Z, et al. A meta-analysis of coffee intake and risk of urolithiasis. Urol Int. 2014; 93(2): 220–228.
  40. Ferraro PM, Cunha TD, Taylor EN, et al. Caffeine intake and the risk of kidney stones. Am J Clin Nutr. 2014; 100(6): 1596–1603.
  41. Lohsiriwat S, Hirunsai M, Chaiyaprasithi B. Effect of caffeine on bladder function in patients with overactive bladder symptoms. Urol Ann. 2011; 3(1): 14–18.
  42. Wijarnpreecha K, Thongprayoon C, Thamcharoen N, et al. Association between coffee consumption and risk of renal cell carcinoma: a meta-analysis. Intern Med J. 2017; 47(12): 1422–1432.
  43. Wu W, Tong Y, Zhao Q, et al. Coffee consumption and bladder cancer: a meta-analysis of observational studies. Sci Rep. 2015; 5: 9051.
  44. Hashemian M, Sinha R, Murphy G, et al. Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst Monogr. 1985; 69(2): 229–234.
  45. Lipton RB, Diener HC, Robbins MS, et al. Caffeine in the management of patients with headache. J Headache Pain. 2017; 18(1): 107.
  46. Jones HE, Herning RI, Cadet JL, et al. Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology (Berl). 2000; 147(4): 371–377.
  47. Couturier EG, Hering R, Steiner TJ. Weekend attacks in migraine patients: caused by caffeine withdrawal? Cephalalgia. 1992; 12(2): 99–100.
  48. Alstadhaug KB, Andreou AP. Caffeine and primary (migraine) headaches-friend or foe? Front Neurol. 2019; 10: 1275.
  49. Shirlow MJ, Mathers CD. A study of caffeine consumption and symptoms; indigestion, palpitations, tremor, headache and insomnia. Int J Epidemiol. 1985; 14(2): 239–248.
  50. Liu QP, Wu YF, Cheng HY, et al. Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies. Nutrition. 2016; 32(6): 628–636.
  51. Larsson SC, Orsini N. Coffee consumption and risk of dementia and Alzheimer's disease: a dose-response meta-analysis of prospective studies. Nutrients. 2018; 10(10).
  52. Eskelinen MH, Ngandu T, Tuomilehto J, et al. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis. 2009; 16(1): 85–91.
  53. Bragança M, Marinho M, Marques J, et al. The influence of espresso coffee on neurocognitive function in HIV-infected patients. AIDS Care. 2016; 28(9): 1149–1153.
  54. Qi H, Li S. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr Gerontol Int. 2014; 14(2): 430–439.
  55. Hong CT, Chan L, Bai CH. The effect of caffeine on the risk and progression of Parkinson's disease: a meta-analysis. Nutrients. 2020; 12(6).
  56. Clark I, Landolt HP. Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials. Sleep Med Rev. 2017; 31: 70–78.
  57. Takabayashi A, Maruyama K, Tanno Y, et al. The association of coffee consumption and oxygen desaturation index during sleep among Japanese male workers. Sleep Breath. 2019; 23(4): 1027–1031.
  58. Grosso G, Micek A, Castellano S, et al. Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies. Mol Nutr Food Res. 2016; 60(1): 223–234.
  59. Wang L, Shen X, Wu Y, et al. Coffee and caffeine consumption and depression: A meta-analysis of observational studies. Aust N Z J Psychiatry. 2016; 50(3): 228–242.
  60. Song Y, Wang Z, Jin Y, et al. Association between tea and coffee consumption and brain cancer risk: an updated meta-analysis. World J Surg Oncol. 2019; 17(1): 51.
  61. Cote DJ, Bever AM, Chiu YH, et al. A prospective study of tea and coffee intake and risk of glioma. Int J Cancer. 2020; 146(9): 2442–2449.
  62. Godavarthy D, Naik R, Gali PK, et al. Can coffee combat caries? An study. J Oral Maxillofac Pathol. 2020; 24(1): 64–67.
  63. Anila Namboodiripad Pc, Kori S. Can coffee prevent caries? J Conserv Dent. 2009; 12(1): 17–21.
  64. Miranda J, Monteiro L, Albuquerque R, et al. Coffee is protective against oral and pharyngeal cancer: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2017; 22(5): e554–e561.
  65. Kim J, Oh SW, Myung SK, et al. Korean Meta-analysis (KORMA) Study Group. Association between coffee intake and gastroesophageal reflux disease: a meta-analysis. Dis Esophagus. 2014; 27(4): 311–317.
  66. Zheng JS, Yang J, Fu YQ, et al. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutr Cancer. 2013; 65(1): 1–16.
  67. Shimamoto T, Yamamichi N, Kodashima S, et al. No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS One. 2013; 8(6): e65996.
  68. Li L, Gan Y, Wu C, et al. Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies. BMC Cancer. 2015; 15: 733.
  69. Wijarnpreecha K, Thongprayoon C, Ungprasert P. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017; 29(2): e8–ee12.
  70. Kennedy OJ, Roderick P, Buchanan R, et al. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Aliment Pharmacol Ther. 2016; 43(5): 562–574.
  71. Yu C, Cao Q, Chen P, et al. An updated dose-response meta-analysis of coffee consumption and liver cancer risk. Sci Rep. 2016; 6: 37488.
  72. Godos J, Micek A, Marranzano M, et al. Coffee consumption and risk of biliary tract cancers and liver cancer: a dose-response meta-analysis of prospective cohort studies. Nutrients. 2017; 9(9).
  73. Kennedy OJ, Roderick P, Buchanan R, et al. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis. BMJ Open. 2017; 7(5): e013739.
  74. Zhang YP, Li WQ, Sun YL, et al. Systematic review with meta-analysis: coffee consumption and the risk of gallstone disease. Aliment Pharmacol Ther. 2015; 42(6): 637–648.
  75. Li TD, Yang HW, Wang P, et al. Coffee consumption and risk of pancreatic cancer: a systematic review and dose-response meta-analysis. Int J Food Sci Nutr. 2019; 70(5): 519–529.
  76. Zhou CD, Kuan AiS, Reeves GK, et al. Million Women Study Collaborators. Coffee and pancreatic cancer risk among never-smokers in the UK prospective Million Women Study. Int J Cancer. 2019; 145(6): 1484–1492.
  77. Sartini M, Bragazzi NL, Spagnolo AM, et al. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective studies. Nutrients. 2019; 11(3).
  78. Bae JM. Coffee consumption and colon cancer risk: A meta-epidemiological study of Asian cohort studies. Asian Pac J Cancer Prev. 2020; 21(5): 1177–1179.
  79. Micek A, Gniadek A, Kawalec P, et al. Coffee consumption and colorectal cancer risk: a dose-response meta-analysis on prospective cohort studies. Int J Food Sci Nutr. 2019; 70(8): 986–1006.
  80. Zhou A, Hyppönen E. Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases. Am J Clin Nutr. 2019; 109(3): 509–516.
  81. D'Elia L, La Fata E, Galletti F, et al. Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies. Eur J Nutr. 2019; 58(1): 271–280.
  82. Miranda AM, Goulart AC, Benseñor IM, et al. Coffee consumption and risk of hypertension: A prospective analysis in the cohort study. Clin Nutr. 2021; 40(2): 542–549.
  83. van Oort S, Beulens JWJ, van Ballegooijen AJ, et al. Association of cardiovascular risk factors and lifestyle behaviors with hypertension: A mendelian randomization study. Hypertension. 2020; 76(6): 1971–1979.
  84. Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, et al. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011; 94(4): 1113–1126.
  85. Mostofsky E, Johansen MB, Lundbye-Christensen S, et al. Risk of atrial fibrillation associated with coffee intake: Findings from the Danish Diet, Cancer, and Health study. Eur J Prev Cardiol. 2016; 23(9): 922–930.
  86. Bodar V, Chen J, Gaziano JM, et al. Coffee consumption and risk of atrial fibrillation in the physicians' health study. J Am Heart Assoc. 2019; 8(15): e011346.
  87. Zuchinali P, Ribeiro PAB, Pimentel M, et al. Effect of caffeine on ventricular arrhythmia: a systematic review and meta-analysis of experimental and clinical studies. Europace. 2016; 18(2): 257–266.
  88. Krittanawong C, Virk H, Farrell A, et al. Association between coffee consumption and risk of heart failure: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2018; 71(11): A865.
  89. Mostofsky E, Rice MS, Levitan EB, et al. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail. 2012; 5(4): 401–405.
  90. Wu Jn, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009; 137(3): 216–225.
  91. Mo L, Xie W, Pu X, et al. Coffee consumption and risk of myocardial infarction: a dose-response meta-analysis of observational studies. Oncotarget. 2018; 9(30): 21530–21540.
  92. Qian Yu, Ye D, Huang H, et al. Coffee consumption and risk of stroke: a mendelian randomization study. Ann Neurol. 2020; 87(4): 525–532.
  93. Shao C, Tang H, Wang X, et al. Coffee consumption and stroke risk: vvidence from a Systematic Review and Meta-Analysis of more than 2.4 Million Men and Women. J Stroke Cerebrovasc Dis. 2021; 30(1): 105452.
  94. Carlström M, Larsson SC. Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev. 2018; 76(6): 395–417.
  95. Kim AnNa, Cho HJ, Youn J, et al. Coffee consumption, genetic polymorphisms, and the risk of type 2 diabetes mellitus: a pooled analysis of four prospective cohort studies. Int J Environ Res Public Health. 2020; 17(15).
  96. Kondo Y, Goto A, Noma H, et al. Effects of coffee and tea consumption on glucose metabolism: a systematic review and network meta-analysis. Nutrients. 2018; 11(1).
  97. Lee A, Lim W, Kim S, et al. Coffee intake and obesity: A meta-analysis. Nutrients. 2019; 11(6).
  98. Cai L, Ma D, Zhang Y, et al. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2012; 66(8): 872–877.
  99. Hallström H, Byberg L, Glynn A, et al. Long-term coffee consumption in relation to fracture risk and bone mineral density in women. Am J Epidemiol. 2013; 178(6): 898–909.
  100. Li S, Dai Z, Wu Q. Effect of coffee intake on hip fracture: a meta-analysis of prospective cohort studies. Nutr J. 2015; 14: 38.
  101. Machado-Fragua MD, Struijk EA, Ballesteros JM, et al. Habitual coffee consumption and risk of falls in 2 European cohorts of older adults. Am J Clin Nutr. 2019; 109(5): 1431–1438.
  102. Moua ED, Hu C, Day N, et al. Coffee consumption and C-reactive protein levels: a systematic review and meta-analysis. Nutrients. 2020; 12(5).
  103. Lyngsø J, Ramlau-Hansen CH, Bay B, et al. Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose-response meta-analysis. Clin Epidemiol. 2017; 9(7): 699–719.
  104. Kawanishi Y, Kakigano A, Kimura T, et al. Hypertensive disorders of pregnancy in relation to coffee and tea consumption: the Japan environment and children's study. Nutrients. 2021; 13(2).
  105. Jeong G, Park SW, Lee YK, et al. Maternal food restrictions during breastfeeding. Korean J Pediatr. 2017; 60(3): 70–76.
  106. Karabegović I, Portilla-Fernandez E, Li Y, et al. Epigenome-wide association meta-analysis of DNA methylation with coffee and tea consumption. Nat Commun. 2021; 12(1): 2830.
  107. Rosenberg K. Meta-analysis shows coffee consumption is generally safe. Am J Nurs. 2018; 118(3): 69–70.
  108. Semiz S, Serdarevic F. Prevention and management of type 2 diabetes and metabolic syndrome in the time of COVID-19: should we add a cup of coffee? Front Nutr. 2020; 7: 581680.
  109. Temple JL. Caffeine use in children: what we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev. 2009; 33(6): 793–806.
  110. Temple JL. Review: trends, safety, and recommendations for caffeine use in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2019; 58(1): 36–45.